Lexaria Bioscience to execute 1-for-15 reverse stock split Aug. 3

Reuters2026/07/30 15:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Lexaria Bioscience will execute a 1-for-15 reverse stock split effective 12:01 a.m. EST on Aug. 3, 2026.
Move targets Nasdaq’s $1 minimum bid price requirement, aiming to regain compliance and support continued listing.
Issued shares to consolidate to 1,652,518 from 24,787,446, with fractional shares rounded up to whole shares.
Authorized shares to drop to 14,666,667 from 220,000,000; par value unchanged, leaving ownership percentages unchanged.
Post-split shares to trade under LEXX with new CUSIP 52886N604; options and warrants to be adjusted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexaria Bioscience Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607301100ACCESSWRNAPR_____1198849) on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Lexaria Bioscience to execute 1-for-15 reverse stock split Aug. 3

You may also like

Crypto prices